$250 | Single User
$500 | Site License
$750 | Global License

McGill University - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 08-11-2018]

Published by Global Data: 08 Nov 2018 | 226763 | In Stock

Introduction

Summary

McGill University (McGill) is a medical-doctoral university. The institute offers undergraduate, graduate, post-graduate courses besides research programs. It provides academic courses across various disciplines including agricultural and environmental sciences, arts, dentistry, education, engineering, law, management, medicine, music and science, among others. The university carries research and licensing technologies in several domains which include agriculture, mechanical and materials, genomics and proteomics, nanotechnologies, climate research, biomedical, network communications, food technology, clean technology, therapeutic agents. McGill works in collaboration with hospitals, research institutions and health centers such as Jewish General Hospital, The Shriners Hospital, St. Mary’s Hospital Center and Douglas Mental Health University Institute. McGill is headquartered in Montreal, Quebec, Canada.

McGill University - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for McGill University - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 08-11-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 5

    List of Figures 5

    McGill University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

    McGill University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

    McGill University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

    McGill University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

    McGill University, Medical Devices Deals, 2012 to YTD 2018 10

    McGill University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

    McGill University, Pharmaceuticals & Healthcare, Deal Details 13

    Partnerships 13

    Lead Discovery Center Enters into Research Agreement with McGill University 13

    Proove Biosciences Enters into Partnership with McGill University 14

    B Cell Design Enters into R&D Agreement with McGill University 15

    IASO BioMed Enters into Research Agreement with Research Institute of the McGill University 16

    Cyclenium Pharma Enters into Research Agreement with McGill University 17

    Neomed Institute Partners with McGill University 18

    MSBi Valorisation, McGill University and Research Institute of the McGill University Health Centre Form Partnership 19

    Viteava Pharma Enters Into Research Agreement With Mcgill University 20

    Licensing Agreements 21

    Aptorum Therapeutics Enters into Licensing Agreement with PolyU Technology and Consultancy, McGill University, Wayne State University, Moffitt Cancer Center and CUHK 21

    Corbin Therapeutics Enters into License Agreement with McGill University 23

    Domain Therapeutics Extends Licensing Agreement with Universite de Montreal and McGill University 24

    IASO BioMed Enters into Licensing Agreement with McGill University 26

    Kinex Pharma Enters into Licensing Agreement with Hong Kong Polytechnic University and McGill University 27

    AUM LifeTech Enters into Licensing Agreement with McGill University 28

    PsychoGenics Enters into Licensing Agreement with McGill University for McGill-R-Thy I-APP 29

    Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 30

    Raptor Pharma Enters Into Licensing Agreement With McGill University For IP Rights Related To Malaria 32

    Asset Transactions 33

    Kanyr Pharma Acquires Rights for Two Cancer Programs from McGill University 33

    McGill University - Key Competitors 34

    McGill University - Key Employees 35

    McGill University - Locations And Subsidiaries 36

    Head Office 36

    Other Locations & Subsidiaries 36

    Joint Venture 36

    Recent Developments 37

    Strategy And Business Planning 37

    Jan 09, 2017: Amorchem Spins Out Its USP15-deubiquitinylation (DUB) Drug Discovery Platform Into Corbin Therapeutics, With A First 1M $ Seed Investment 37

    Government and Public Interest 38

    Aug 16, 2018: The Government of Quebec Grants 0,000 to McGill University and RI-MUHC to Support Two Collaborative Projects 38

    Jun 19, 2018: Alzheimer Society Research Program awards .9 million to Canadian researchers 39

    May 07, 2018: A new molecular target identified in depression 40

    May 03, 2018: Early HIV treatment key to avoiding brain atrophy 41

    Apr 26, 2018: Extraordinary -million gift will create unique powerhouse initiative to fight infections 42

    Mar 08, 2018: Canadian researchers open a new front in the fight against MS 44

    Mar 01, 2018: A near-universal way to measure enzyme inhibition 45

    Feb 21, 2018: McGill-led genomics centres win .8 M, three-year funding support from Genome Canada 46

    Feb 20, 2018: Products derived from plants offer potential as dual-targeting agents for experimental cerebral malaria 47

    Feb 19, 2018: Government of Canada and Brain Canada announce a -million grant to establish a platform that will help researchers share data more widely and efficiently 48

    Jan 31, 2018: McGill research team studies how calcium compounds accumulate in the arteries 49

    Jan 30, 2018: Epigenetic alteration of a vitamin B12 processing gene shines new light on our understanding of rare diseases 51

    Jan 11, 2018: Progression of Parkinson’s disease follows brain connectivity 52

    Oct 23, 2017: Transformative donation of million establishes new autism research centre at the Montreal Neurological Institute 53

    Oct 13, 2017: New mechanism detected in Alzheimer’s disease 54

    Oct 13, 2017: Neurotechnological innovation and organ-on-a-chip engineering centres receive more than million in new funding 55

    Sep 06, 2017: Scientists link 153 new genetic variants to osteoporosis in largest ever study 56

    May 15, 2017: Diabetes drug may help symptoms of autism associated condition 57

    Jan 09, 2017: Breakthrough in MS treatment 58

    Product News 59

    Jul 10, 2018: Unique brain “fingerprint” can predict drug effectiveness 59

    Other Significant Developments 60

    Jul 04, 2018: Pathway of Alzheimer’s degeneration discovered 60

    Jul 04, 2018: HPV testing could be more accurate than smear tests for initial screening of cervical cancer 61

    Apr 25, 2018: Quebec patients poised to benefit from major investments in genomics research and precision health 63

    Appendix 64

    Methodology 64

    About GlobalData 64

    Contact Us 64

    Disclaimer 64

List Of Tables
in McGill University - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 08-11-2018]

List of Tables

McGill University, Pharmaceuticals & Healthcare, Key Facts 2

McGill University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

McGill University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

McGill University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

McGill University, Deals By Therapy Area, 2012 to YTD 2018 9

McGill University, Medical Devices Deals, 2012 to YTD 2018 10

McGill University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Lead Discovery Center Enters into Research Agreement with McGill University 13

Proove Biosciences Enters into Partnership with McGill University 14

B Cell Design Enters into R&D Agreement with McGill University 15

IASO BioMed Enters into Research Agreement with Research Institute of the McGill University 16

Cyclenium Pharma Enters into Research Agreement with McGill University 17

Neomed Institute Partners with McGill University 18

MSBi Valorisation, McGill University and Research Institute of the McGill University Health Centre Form Partnership 19

Viteava Pharma Enters Into Research Agreement With Mcgill University 20

Aptorum Therapeutics Enters into Licensing Agreement with PolyU Technology and Consultancy, McGill University, Wayne State University, Moffitt Cancer Center and CUHK 21

Corbin Therapeutics Enters into License Agreement with McGill University 23

Domain Therapeutics Extends Licensing Agreement with Universite de Montreal and McGill University 24

IASO BioMed Enters into Licensing Agreement with McGill University 26

Kinex Pharma Enters into Licensing Agreement with Hong Kong Polytechnic University and McGill University 27

AUM LifeTech Enters into Licensing Agreement with McGill University 28

PsychoGenics Enters into Licensing Agreement with McGill University for McGill-R-Thy I-APP 29

Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 30

Raptor Pharma Enters Into Licensing Agreement With McGill University For IP Rights Related To Malaria 32

Kanyr Pharma Acquires Rights for Two Cancer Programs from McGill University 33

McGill University, Key Competitors 34

McGill University, Key Employees 35

McGill University, Subsidiaries 36

McGill University, Joint Venture 36

List Of Figures, Charts and Diagrams
in McGill University - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 08-11-2018]

List of Figures

McGill University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

McGill University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

McGill University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

McGill University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

McGill University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

McGill University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

McGill University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

McGill University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

McGill University, Medical Devices Deals, 2012 to YTD 2018 10

Additional Details

Publisher

Global Data

Publisher Information

Reference

226763 | GDPH231785D

Number of Pages

64

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
McGill University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryMcGill University (McGill) is a medical-doctoral university. The institute offers undergradua...
24 Jul 2018 by Global Data USD $250 More Info
McGill University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryMcGill University (McGill) is a medical-doctoral university. The institute offers undergradua...
23 Apr 2018 by Global Data USD $250 More Info
McGill University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryMcGill University (McGill) is a research based educational institute. The university offers u...
13 Mar 2018 by Global Data USD $250 More Info
McGill University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryMcGill University (McGill) is a research based educational institute. The university offers u...
23 Aug 2017 by Global Data USD $250 More Info
McGill University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryMcGill University (McGill) is a research based educational institute. The university offers u...
23 Aug 2017 by Global Data USD $250 More Info
McGill University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryMcGill University (McGill) is a research based educational institute. The university offers u...
10 May 2017 by Global Data USD $250 More Info
McGill University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryMcGill University (McGill) is a research based educational institute. The university offers u...
17 Feb 2017 by Global Data USD $250 More Info
McGill University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryMcGill University (McGill) is a research based educational institute. The university offers u...
19 Dec 2016 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

McGill University - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 08-11-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data